Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs Academic Article uri icon


MeSH Major

  • Antipsychotic Agents
  • Central Nervous System Stimulants
  • Corpus Striatum
  • Dopamine and cAMP-Regulated Phosphoprotein 32
  • Neurons


  • DARPP-32 is a dual-function protein kinase/phosphatase inhibitor that is involved in striatal signaling. The phosphorylation of DARPP-32 at threonine 34 is essential for mediating the effects of both psychostimulant and antipsychotic drugs; however, these drugs are known to have opposing behavioral and clinical effects. We hypothesized that these drugs exert differential effects on striatonigral and striatopallidal neurons, which comprise distinct output pathways of the basal ganglia. To directly test this idea, we developed bacterial artificial chromosome transgenic mice that allowed the analysis of DARPP-32 phosphorylation selectively in striatonigral and striatopallidal neurons. Using this new methodology, we found that cocaine, a psychostimulant, and haloperidol, a sedation-producing antipsychotic, exert differential effects on DARPP-32 phosphorylation in the two neuronal populations that can explain their opposing behavioral effects. Furthermore, we found that a variety of drugs that target the striatum have cell type-specific effects that previous methods were not able to discern.

publication date

  • August 2008



  • Academic Article



  • eng

PubMed Central ID

  • PMC2737705

Digital Object Identifier (DOI)

  • 10.1038/nn.2153

PubMed ID

  • 18622401

Additional Document Info

start page

  • 932

end page

  • 9


  • 11


  • 8